This conference will present the most current information on multidisciplinary approaches in clinical oncology and will consist of tumor board cases on breast, gastrointestinal, genitourinary, head and neck/non-thyroid, hematologic malignancies, lymphoma, melanoma, sarcoma, and thoracic cancers. The tumor board cases will be presented by faculty, with discussion by a panel of surgical, radiation, and medical...

In this interactive case-based activity, Mihaela Cristea, MD, City of Hope, will discuss emerging data on PARP inhibitors in the management of recurrent ovarian cancer and case studies that provide a framework for personalized care plans.

Join Caroline Behler, MD,, on May 1 at 6:30PM to review data from 2 pivotal trials assessing Adcetris+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and Adcetris+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphoma (PTCL).

The AIM Planning Committee invites you to attend this Inaugural AIM Investigator Conference.

This exciting one-day conference will feature a lineup of nationally-recognized speakers who will address payment reform, medical-dental integration, health plan perspectives, and other current topics.

Join Caroline Behler, MD, as she reviews data from 2 pivotal trials assessing Adcetris+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and Adcetris+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphomas (PTCL).

Join Babis Andreadis, MD, UC San Francisco, Brian A. Jonas, MD, PhD, UC Davis, and Michaela Liedtke, MD, Stanford University as they present the latest treatment modalities for hematologic malignancies. Alfred Chung, MD, Stanford University will then present cases for discussion illustrating the new treatment modalities.

On July 1, 2017, California' out-of-network billing and payment law (AB 72) went into effect. This law changed the billing practices of non-participating physicians providing non-emergent care at in-network facilities by requiring payors to reimburse at an interim payment rate. This law also created a dispute resolution mechanism for physicians who believe the interim payment...

The California Prostate Cancer Coalition (CPCC) and the Helen Diller Family Comprehensive Cancer Center of UC San Francisco proudly present this national conference for patients, families, caregivers, health care professionals and advocates.